Liqiang Zhong
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Study of Apatinib Combined With Second - Line Chemotherapy for Metastatic Colorectal Cancer (NCT03412994) | Liqiang Zhong | 2018-02-28 |
Track Liqiang Zhong automatically
Every clearance here is in the API, with alerts when new ones post.